Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need. Penumbra sells its products to hospitals and healthcare providers primarily through its direct sales organization in the United States, most of Europe, Canada and Australia, and through distributors in select international markets. The Penumbra logo is a trademark of Penumbra, Inc. Members of the Penumbra team agree that this is where their work has meaning -- we are transforming the treatment of some of the world's most devastating conditions. Penumbra is where everyone's ideas matter, and where learning and growth are constant. No. 5 on the Greater Bay Area Manufacturers List, San Francisco Business Times, 2020 100 Fastest-Growing Companies, Fortune, 2019 Review our community guidelines for LinkedIn here: https://bit.ly/2Jmbw83.
External link for Penumbra, Inc.
One Penumbra Place
Alameda, CA 94502, US
Penumbra, Inc. reposted this
US HCPs: Listen to Dr. Suhail Dohad discuss insights on the upcoming STORM-PE RCT comparing anticoagulation, the standard of care, versus #CAVT with anticoagulation. Rx only. Risk info: peninc.info/risk Clinical results may vary
#YearInReview: Penumbra was recognized by Medical Device Network with their Innovation Award and Inc. Magazine Best In Business Award. These accolades highlight our dedication to advancing innovation and improving patient outcomes worldwide. Read more below: Med Device Network: https://lnkd.in/gDbMEBBs Inc: https://lnkd.in/gTEq_Cv7 #MedTech #HealthTech #Innovation #PenumbraProud
Penumbra, Inc. reposted this
US HCPs: Dr. Suhail Dohad comments on the importance of an RCT in the PE clinical trial landscape. #LeadWithCAVT Rx only. Risk info: peninc.info/risk Clinical results may vary
FLIP ended 2024 on a high note with the Therapy Access: Pathways for Stroke course in NYC 🎉 Big thank you to Dr. Dan Sahlein & Dr. David Altschul for sharing your insights and expertise! #FellowsLeapingIntoPractice
Penumbra, Inc. reposted this
US HCPs: Dennys Reyes MD FAHA Reyes addressed a right M1 occlusion with #RED72 + #SENDit. The team achieved a first-pass TICI 3 result in 6 minutes. System supported by #BMX96. Excellent work, Dr. Reyes and team! Rx only. Risk: peninc.info/risk Clinical results may vary
US HCPs: Latest data shows benefits of #CAVT for #PE patients and improvements to health system resource utilization. Read more here: https://lnkd.in/g2RFKFVH #Innovation #MedTech #YearInReview Rx only. Risk info: peninc.info/risk Clinical results may vary
Penumbra, Inc. reposted this
US HCPs: ❗Latest results from STRIKE-PE, including the #LightningFlash subset, support the use of #CAVT as a frontline solution for treatment of intermediate to high-risk PE, evaluating real-world safety, performance, and quality of life outcomes. #LeadWithCAVT designed for #Speed, #Safety, and #Simplicity. Rx only. Risk: peninc.info/risk Clinical results may vary
Penumbra, Inc. reposted this
US HCPs: Ruptured 24mm Fetal PCOM aneurysm managed with 8 complex coils and #swiftPAC packing coils. #swiftPAC coil sequence: (2) 60cm, (2) 45cm, (1) 30cm. System supported with #BENCHMARK71 + #MIDWAY43. Courtesy of Dr. Dennys Reyes! Rx only. Risk: peninc.info/risk Clinical results may vary.
Penumbra, Inc. reposted this
Check out this video of the Penumbra #swiftPAC Packing Coil in action! #liquidmetal Learn more here: https://lnkd.in/gKGQm3fC Rx only. Risk info: peninc.info/risk Clinical results may vary
Penumbra, Inc. reposted this
Blink and you’ll miss it! #RED72 + #SENDit track smoothly up to a left M1 occlusion, achieving a first-pass TICI 3 in 2 minutes. Congratulations to Ryan Hebert MD & team! Rx only. Risk: peninc.info/risk Clinical results may vary